TAT and Parkinson disease: In addition, to evaluate whether the delivery of Tat-GSTpi proteins to the brain could protect against dopaminergic neuronal cell death in the MPTP-induced PD model, we performed immunostaining with tyrosine hydroxylase (TH) antibody and cresyl violet (CV).